Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million ...

Out-of-hospital mortality before 30 days was 1.2%, with roughly two-thirds of these patients dying from cardiovascular causes ...

Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...

Doctors at Duke Health have successfully performed the world’s first living mitral valve replacement, saving three lives in North Carolina.

Kirkland-based heart care company Cardiac Dimensions on Thursday raised a $53 million Series E round.

Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.

Partial heart transplants provide a range of lifesaving options for children with complex congenital heart conditions, and ...

ST. LOUIS — Dr. Scally, a cardiothoracic surgeon with Prairie Cardiovascular in O’Fallon, Illinois, explains mitral valve disease, a condition that affects the mitral valve, which controls ...

The Duke team performed the world’s first living mitral valve replacement, a type of partial heart transplant, which Duke ...

Growing investments in healthcare infrastructure and advancements in medical research facilities are driving the expansion of ...

Rising prevalence of cardiovascular diseases and rapid advancements in minimally invasive procedures are fueling the growth ...